Project Grant K23HL173709
Award Date
8/15/24
Completion Date
7/31/29
Dollars Obligated
$344K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The federal Project Grant award K23HL177175 for $174,960.00 was provided by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research program (CFDA 93.837). This award supports Dr. Elizabeth Munroe, a rising clinician-scientist at the University of Michigan, in developing and evaluating a personalized approach to initial fluid resuscitation for patients with hospital-onset sepsis. The project aims to 1)...
This Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), is funding research to develop hemostatic red blood cells (T-RBCs) for the treatment of acute non-compressible hemorrhage. The $234,000 award, active from March 1, 2025 to February 28, 2027, will support the synthesis and in vitro/in vivo testing of these T-RBCs, which are engineered to adhere to collagen and fibrin clots to help stop...
This federal Project Grant award, totaling $249,000.00, was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports the development of methodologies to reveal the role of the blood microbiome in the gut-lung axis for asthma pathogenesis. The project aims to develop a strain-resolved computational pipeline for reduced metagenomic sequencing to profile the blood microbiome, and a deep learning framework to...
This federal Project Grant award for $762,405.80 was provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports research to investigate the role of cell-free hemoglobin (CFH) and oxidized low-density lipoprotein (OxLDL) in disrupting the microvascular endothelial cell barrier, leading to lung injury and acute respiratory distress syndrome (ARDS) during sepsis. The research aims to elucidate the cellular and...
This federal Project Grant award for $445,708.00, provided by the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to define the role of platelet ABO(H) blood group antigens in hemostasis and thrombosis. The key objectives are to: 1) Determine the impact of ABO(H) glycans on platelet binding to von Willebrand factor (vWF), and 2) Identify the platelet glycoproteins that carry ABO(H) antigens using a click...
This $181,772 project grant from the National Heart, Lung and Blood Institute will support research into coagulopathy in sepsis patients. The grantee, Beth Israel Deaconess Medical Center, will conduct an ancillary study using viscoelastic monitoring to examine the effects of randomly assigned fluid resuscitation strategies on coagulation parameters in sepsis patients. Specifically, the study aims to: 1) analyze how liberal versus restrictive fluid administration impacts coagulation measurements...
This Project Grant award, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), will fund a collaborative research program to investigate fundamental questions surrounding anti-ABO(H) antibodies and their target antigens on red blood cells. The $5,187,690 award, with a performance period from August 1, 2024 to July 31, 2029, will support three distinct research projects and complementary core facilities led by a multidisciplinary team of...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $295,963 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to New Health Sciences, Inc. (Hemanext Inc.) to evaluate the hemostatic function of platelets stored under hypoxic conditions for whole blood (WB) transfusion. The project aims to develop an improved WB storage platform that maintains an oxygen-managed environment to provide higher quality red blood cells for oxygen delivery and shock reversal, while...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $465,000.00 to Bloodworks, a non-profit organization based in Seattle, Washington. The funding supports research into inflammation-associated autophagy dysfunction in sickle cell disease (SCD). The research aims to investigate how tumor necrosis factor-alpha (TNF-α) driven inflammation in SCD disrupts autophagy and mitophagy in...
This federal Project Grant award of $930,481.00 from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund research on synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis. The research will be conducted by a K12 postdoctoral scholar at the University of North Texas, a Hispanic-serving research institution. The key objectives are to determine the nature of interaction between the...